SCHEMBL11264148

SCHEMBL11264148

CC=CCOC(=O)OCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
SOAT1 P35610 1/20 0.48
HSD17B10 Q99714 2/20 0.39
LMNA P02545 1/20 0.39
ALOX15 P16050 2/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
HCAR2 Q8TDS4 1/20 0.35
NR1I2 O75469 1/20 0.35
PGR P06401 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
PTGS2 P35354 1/20 0.35
PDE4D Q08499 1/20 0.35
TRPA1 O75762 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GLO1 Q04760 1/20 0.34
CYP1A2 P05177 1/20 0.34
FAAH O00519 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15450092 1.00 ALDH1A1 (0.59) ALDH1A1SOAT1HSD17B10LMNAALOX15
SCHEMBL1598833 0.91 ALDH1A1 (0.41) ALDH1A1SOAT1ALOX15
SCHEMBL10595745 0.91 ALDH1A1 (0.41) ALDH1A1SOAT1ALOX15
SCHEMBL28101735 0.83 ALDH1A1 (0.77) ALDH1A1SOAT1HSD17B10LMNAALOX15
SCHEMBL9623186 0.82 ALDH1A1 (0.59) ALDH1A1SOAT1HSD17B10LMNAALOX15
SCHEMBL1216481 0.81
SCHEMBL3455393 0.80 CYP1A2 (0.47) ALDH1A1HSD17B10LMNAALOX15MGAM
SCHEMBL23388854 0.80 ALDH1A1 (0.56) ALDH1A1SOAT1HSD17B10LMNAALOX15
SCHEMBL12097090 0.80 ALDH1A1 (0.56) ALDH1A1SOAT1HSD17B10LMNAALOX15
SCHEMBL12097092 0.80 ALDH1A1 (0.56) ALDH1A1SOAT1HSD17B10LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250296933-A1 METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. 2025-09-25 US disclosed
US-4362670-A Allylation of carbon compounds THE DOW CHEMICAL COMPANY (US) 1982-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250296933-A1 METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS CYP11B1, CYP11A1, CYP11B2 ALDH1A1 205/4885SOAT1 327/4885HSD17B10 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.